As medicine takes an increasingly evidence-based approach to care, it's more important than ever for busy clinicians to be able to evaluate the benefits and risk-reduction associated with new treatments and medications. This week's guest, Tom Bartol, nurse practitioner at the Richmond Area Health Center in Richmond, Maine, discusses with host Mimi Secor how to wade through the research data and evaluate statistical significance versus clinical significance, and find the information you need in order to treat your patients more effectively.
Quick and Accurate Research Evaluation for Busy Clinicians

Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
As medicine takes an increasingly evidence-based approach to care, it's more important than ever for busy clinicians to be able to evaluate the benefits and risk-reduction associated with new treatments and medications. This week's guest, Tom Bartol, nurse practitioner at the Richmond Area Health Center in Richmond, Maine, discusses with host Mimi Secor how to wade through the research data and evaluate statistical significance versus clinical significance, and find the information you need in order to treat your patients more effectively.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
FCS and SHTG: Are We Meeting the Need?
IgG4-RD Case Conversations: Systemic Disease Infiltrating the Skull Base
Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time
Integrating Guideline Directed Medical Therapy for Patients with CKD and T2D
HF Management for Patients with Comorbid Conditions
Kidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial
FINE-HEART Pooled Analysis
Mode of Death in Patients With HFmrEF/HFpEF: The FINEARTS-HF Trial
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?